Skip to main content
TERUMO CORPORATION logo

TERUMO CORPORATION — Investor Relations & Filings

Ticker · 4543 ISIN · JP3546800008 LEI · 353800JX1R4582QVK932 SGX Manufacturing
Filings indexed 89 across all filing types
Latest filing 2023-06-28 Annual Report
Country JP Japan
Listing SGX 4543

About TERUMO CORPORATION

https://www.terumo.co.jp/

Terumo Corporation is a global medical technology company that develops, manufactures, and markets a broad portfolio of medical devices, equipment, and solutions. Its core business activities are centered on several key areas: Cardiac and Vascular, Blood and Cell Technologies, and Hospital and Pharmaceutical Solutions. The Cardiac and Vascular business provides products for interventional procedures, neurovascular therapies, and cardiovascular surgery. The Blood and Cell Technologies division offers solutions for blood transfusion, apheresis, and cell therapy processing. The company also supplies general hospital products, including infusion systems and medical disposables, alongside life care products for consumers and specialized pharmaceutical solutions that integrate drugs with delivery devices.

Recent filings

Filing Released Lang Actions
有価証券報告書-第108期(2022/04/01-2023/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header information for Terumo Corporation for the fiscal year ending March 31, 2023, and includes XBRL-like tagging for financial statements and corporate data, confirming it is the full annual filing rather than an announcement or summary. FY 2023
2023-06-28 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of the Quarterly Report (Shihanki Hokokusho) for the third quarter of the 108th fiscal period. Since this is a regulatory filing confirming the validity of a financial report rather than the report itself, and it does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing.
2023-02-13 Japanese
四半期報告書-第108期第3四半期(2022/10/01-2022/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Terumo Corporation with the Kanto Local Finance Bureau in Japan. It covers the third quarter of the 108th fiscal year (period from April 1, 2022, to December 31, 2022). It contains detailed financial statements, management analysis, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-02-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan, specifically confirming the accuracy of the contents of a Quarterly Report (Shihanki Hokokusho). Since this is a regulatory filing confirming the validity of a financial report rather than the report itself, and it does not fit into the specific categories of financial statements or management reports, it is classified as a general regulatory filing.
2022-11-14 Japanese
四半期報告書-第108期第2四半期(令和4年7月1日-令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Terumo Corporation with the Kanto Local Finance Bureau. It contains detailed financial statements, management analysis (MDA), and corporate information for the second quarter of the 108th fiscal period (July 1, 2022, to September 30, 2022). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q2 2022
2022-11-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It serves as a formal certification by the CEO regarding the accuracy of the quarterly report (108th term, Q1). Since this is a standalone regulatory certification document required by law to accompany financial filings rather than the financial report itself, and it does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing.
2022-08-12 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.